BioSpace News Archive

Drug Development

Puma’s Nerlynx Edges Out Novartis’ Tykerb in Breast Cancer Trial

Patients were randomized 1:1 to receive Nerlynx and Xeloda or Tykerb and Xeloda. Co-primary endpoints were progression-free survival and overall survival.

May 17, 2019
·
2 min read
·
Mark Terry
Business

QIAGEN and Inovio Team Up to Create Companion Diagnostic for HPV Cervical Dysplasia

The collaboration will focus on Inovio’s VGX-3100, which stimulates a specific immune response to HPV-16 and HPV-18, targeting the infection and causing destruction of precancerous cells.

May 17, 2019
·
3 min read
·
Mark Terry
Business

Housing Group Ranks 10 Best and Worst Metro Areas to Live in for STEM Jobs

Some of the biggest hubs for biotech and pharma fared poorly in the rankings due to housing affordability.

May 17, 2019
·
2 min read
·
Alex Keown
Drug Development

Clinical Catch-up from Last Week: May 13-17

Here’s a roundup of some of the top clinical trial news from the previous week.

May 17, 2019
·
8 min read
·
Mark Terry
Pharm Country

Exclusive: BeyondSpring’s Plinabulin Reduces Bone Pain in CIN Patients

Lan Huang, chief executive officer of BeyondSpring, believes her company has the “secret sauce” that could provide beneficial treatment to chemotherapy-induced neutropenia, a common side effect for chemotherapy patients.

May 17, 2019
·
3 min read
·
Alex Keown
FDA

FDA Approves First VTE Treatment for Pediatric Patients

Pfizer’s Fragmin was approved to reduce the recurrence of VTE in patients one month of age or older.

May 17, 2019
·
2 min read
·
Alex Keown
Lone Star Bio

Actuate Therapeutics Secures $21.7 Million to Support Phase I/II Clinical Trial

The company took its GSK-3B inhibitor into the clinic earlier this year. The drug is being studied in patients with refractory hematologic malignancies or solid tumors.

May 17, 2019
·
2 min read
·
Alex Keown
Policy

FDA’s Project Facilitate to Launch by End of May

Project Facilitate is a pilot project to create a single point of contact for the FDA’s oncology expanded access requests.

May 17, 2019
·
3 min read
·
Mark Terry
Drug Development

AbbVie Halts Brain Tumor Study Due to Lack of Survival Benefits

An Independent Data Monitoring Committee recommended the trial be stopped because of lack of survival benefit for patients receiving the drug compared to placebo.

May 17, 2019
·
2 min read
·
Mark Terry
Career Advice

Tips for Reentering the Life Sciences Workforce

Life is full of twists and turns, but there are always new opportunities around the corner, even when we hit the pause button on our careers. Getting back into the industry doesn’t have to be scary or overwhelming. You can have a successful job search if you take a step-by-step approach.

May 17, 2019
·
4 min read
·
Yaffa Grace